Investment
Features
FeesSafety
Academy
More
Pluang+

Alstom reports 4.9% revenue growth in Q1 2026/27 with key project milestones and confirms full-year outlook.

Company Fundamentals
22 Jul 2026
Alstom S.A
View Source
Bullish
pluang ai news

Alstom announced a 4.9% increase in revenue to €4.734 billion for Q1 of fiscal year 2026/27, driven by strong performance in rolling stock, services, and signaling. Despite a 37% drop in new orders to €2.56 billion, the company achieved major operational milestones including TGV-M certification and new train deployments across multiple regions. Alstom confirmed its full-year guidance with expected organic revenue growth of around 5%, an adjusted operating margin of about 6.5%, and positive free cash flow generation. The company aims to improve operational execution and profitability, with a detailed medium-term plan to be presented in early 2027.

More News

Stewart Information Services expects Q2 EPS of $1.63 and $838M revenue, with earnings due July 22.

Stewart Information Services expects Q2 EPS of $1.63 and $838M revenue, with earnings due July 22.

Stewart Information Services Corporation is set to report its Q2 earnings on July 22, 2026, with analysts forecasting an EPS of $1.63 and revenue around $838 million. The company, a leader in title insurance and real estate services, shows a solid fi...

Company Fundamentals
Neutral
1 hour ago
Ipsen corrects its June 2026 report on total shares and voting rights due to a data error.

Ipsen corrects its June 2026 report on total shares and voting rights due to a data error.

Ipsen Pharma issued a correction to its monthly report on the total number of shares and voting rights as of June 30, 2026. The correction addresses a material error in the previously published figures for both gross and net voting rights. The update...

Company Fundamentals
Neutral
1 hour ago
Ipsen corrects voting rights data for June 30, 2026, adjusting total shares and voting rights figures.

Ipsen corrects voting rights data for June 30, 2026, adjusting total shares and voting rights figures.

Ipsen Pharma issued a corrective statement to amend its previously published monthly disclosure of the total number of shares and voting rights as of June 30, 2026. The correction addresses a material error in the reported gross and net voting rights...

Company Fundamentals
Neutral
1 hour ago
Alstom reports Q1 FY 2026/27 sales up 4.9%, confirms full-year outlook amid key operational milestones.

Alstom reports Q1 FY 2026/27 sales up 4.9%, confirms full-year outlook amid key operational milestones.

Alstom posted a 4.9% increase in sales to €4.73 billion for Q1 FY 2026/27, driven by progress in rolling stock, services, and signalling. Despite a 37% drop in orders to €2.56 billion, the company achieved major milestones including TGV-M homologatio...

Company Fundamentals
Bullish
1 hour ago
Teledyne Technologies beats Q2 earnings estimates with $6.28 EPS, driven by strong demand and raises 2026 profit forecast.

Teledyne Technologies beats Q2 earnings estimates with $6.28 EPS, driven by strong demand and raises 2026 profit forecast.

Teledyne Technologies reported strong Q2 2026 results, with earnings per share of $6.28 beating estimates by 8.65% and revenue of $1.66 billion surpassing expectations. The company saw a 20.8% increase in EPS and a 9.8% rise in revenue year-over-year...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App